| The
Company’s primary product is the ICOLENS™ system, a
patented refractive solution that is designed to restore
near vision loss caused by
the eye’s natural aging process
without significant side effects.
In 2010, Neoptics will commence clinical trials at selected
eye clinics across Western Europe in 2010. |